Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

Abroad (travel likely)RecruitingPHASE2

Conditions

Achondroplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • UCSF Benioff Children's Hospital, Oakland, California, United States

  • Johns Hopkins University, Baltimore, Maryland, United States

  • University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison, Wisconsin, United States

  • Murdoch Children's Research Institute, Parkville, Victoria, Australia

  • Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada

  • Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada

  • Paediatric Clinical Research Unit at Oslo University Hospital, Oslo, Norway

  • KK Women's and Children's Hospital, Singapore, Singapore

  • Unidad de Cirugía Artroscópica (UCA), Vitoria-Gasteiz, Spain

  • NHS Greater Glasgow and Clyde, Glasgow, United Kingdom

  • Manchester University NHS Foundation Trust, Manchester, United Kingdom

  • Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom